Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01943539 · ClinicalTrials.gov registry record · NA

Cognitive ADHD Videogame Exploratory Study

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Akili Interactive Labs.

Completed
Registry status
NA
Development phase
84
Enrollment target
2
Study locations

NCT01943539 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by Akili Interactive Labs. The registered enrollment target is 84 participants, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01943539, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by Akili Interactive Labs.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
2
Study locations

Study Summary

A study in ADHD and neuro-typical children to assess EVO game play over 29 days.

Interventions

  • DEVICE Neuro-typical controls and ADHD will receive EVO game play.

Study Locations (2)

Florida

  • Florida Clinical Research Center, LLC - Bradenton

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2013-09
Est. Completion 2015-05
Phase NA

Sponsor

Akili Interactive Labs

13 total trials

What the Registry Record Tells You About NCT01943539

The ClinicalTrials.gov registry entry for NCT01943539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (59% lower). The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Neuro-typical controls and ADHD will receive EVO game play. is the first listed.

NCT01943539 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, North Carolina.

Frequently Asked Questions

What is clinical trial NCT01943539 about?

NCT01943539 is a clinical study titled "Cognitive ADHD Videogame Exploratory Study". A study in ADHD and neuro-typical children to assess EVO game play over 29 days.

What is the current status of trial NCT01943539?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2013-09. Estimated completion is 2015-05.

What conditions does trial NCT01943539 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT01943539?

The interventions under investigation include: Neuro-typical controls and ADHD will receive EVO game play. (DEVICE).

Who is sponsoring clinical trial NCT01943539?

This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01943539 being conducted?

This trial has 2 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.